Literature DB >> 2647

Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement.

J Chapitis, I H Lepow.   

Abstract

Normal human serum subjected to sucrose density gradient analysis exhibited multiple sedimenting species of properdin antigen. Properdin antigen distribution was dependent on serum concentration, ionic strength, temperature, and the presence of C3, and was not dependent on the presence of divalent metal cations or blood coagulation. In mixtures of purified components, properdin sedimented heavier in the presence of C3, C3b, or C3c. Addition of factor B to mixtures containing C3 and properdin was without effect. These data provide insights into earlier discrepancies concerning the sedimentation behavior of partially purified properdin, indicate a propensity of some constituents of the alternative pathway to form protein-protein complexes, and suggest caution in interpretation of immunopathological studies in which properdin deposits are found in the presence of C3.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 2647      PMCID: PMC2190122          DOI: 10.1084/jem.143.2.241

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Changes in the immunochemical properties of highly purified properdin in human serum.

Authors:  J O Minta
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

3.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

4.  The properdin system and immunity. X. Characterization of partially purified human properdin.

Authors:  I H LEPOW; L PILLEMER; M D SCHOENBERG; E W TODD; R J WEDGWOOD
Journal:  J Immunol       Date:  1959-10       Impact factor: 5.422

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

7.  Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.

Authors:  R D Schreiber; R G Medicus; O Gïtze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

8.  Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

Authors:  H J Müller-Eberhard; M J Polley; M A Calcott
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

9.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Complement: an overview for the clinician.

Authors:  Juan Carlos Varela; Stephen Tomlinson
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

2.  Cryoglobulinaemia in Henoch-Schönlein purpura.

Authors:  M Garcia-Fuentes; C Chantler; D G Williams
Journal:  Br Med J       Date:  1977-07-16

3.  Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

4.  Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

5.  Resolution and analysis of 'native' and 'activated' properdin.

Authors:  T C Farries; J T Finch; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 6.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

Review 7.  Complementopathies and precision medicine.

Authors:  Eleni Gavriilaki; Robert A Brodsky
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

8.  Mapping of the properdin-binding site in the third component of complement.

Authors:  J D Lambris; J Alsenz; T F Schulz; M P Dierich
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

9.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

10.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.